Funding for this research was provided by:
Conseil Régional Normandie
Etablissement Français du Sang
Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques
Instituto de Salud Carlos III (RD16-0015-0019, PI15/00963, PI18/00357)
Consejería de Sanidad de Castilla-La Mancha (II-2018_07)
Received: 10 June 2020
Accepted: 3 February 2021
First Online: 20 February 2021
Ethics approval and consent to participate
: Animal experiments were performed following European, national, and institutional guidelines for the care and use of animals. All procedures were performed according to the guidelines of the institutional ethics committee (<i>Comité Normand d’éthique en matière d’expérimentation animale</i> (CeNomExa) and <i>Comité Ético de Experimentación Animal del Hospital Nacional de Parapléjicos</i>). Projects were submitted to and approved by these committees in accordance with the European directive no. 2013/63/UE (agreement number D14118001) and with the French and Spanish National and Regional Guidelines for Animal Experimentation and the Use of Genetically Modified Organisms (French Ministry of Research, project license number 02653.2, Decree 87/848; RD 53/2013 and 178/2004, Law 32/2007 and 9/2003, Decree 320/2010).
: Not applicable
: The authors declare no competing interests.